Verve Therapeutics
VERV
#7075
Rank
HK$3.03 B
Marketcap
HK$35.79
Share price
1.10%
Change (1 day)
-59.86%
Change (1 year)

Earnings for Verve Therapeutics (VERV)

Earnings in 2024 (TTM): -HK$1.74 Billion

According to Verve Therapeutics's latest financial reports the company's current earnings are HK$20.64 Million. In 2023 the company made an earning of -HK$1.74 Billion a decrease over its 2022 earnings that were of -HK$1.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verve Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$1.74 Billion-0.04%
2023 -HK$1.74 Billion34.67%
2022 -HK$1.29 Billion90.3%
2021 -HK$0.68 Billion114.31%
2020 -HK$0.32 Billion